These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 9371511)
1. Hypersensitivity to DNA cross-linking agents associated with up-regulation of glucose-regulated stress protein GRP78. Chatterjee S; Hirota H; Belfi CA; Berger SJ; Berger NA Cancer Res; 1997 Nov; 57(22):5112-6. PubMed ID: 9371511 [TBL] [Abstract][Full Text] [Related]
2. Increased sensitivity of human colon cancer cells to DNA cross-linking agents after GRP78 up-regulation. Belfi CA; Chatterjee S; Gosky DM; Berger SJ; Berger NA Biochem Biophys Res Commun; 1999 Apr; 257(2):361-8. PubMed ID: 10198218 [TBL] [Abstract][Full Text] [Related]
3. Analysis of cellular sensitization with cisplatin-induced apoptosis by glucose-starved stress in cisplatin-sensitive and -resistant A431 cell line. Mese H; Sasaki A; Nakayama S; Yokoyama S; Sawada S; Ishikawa T; Matsumura T Anticancer Res; 2001; 21(2A):1029-33. PubMed ID: 11396136 [TBL] [Abstract][Full Text] [Related]
4. Induction of M(r) 78,000 glucose-regulated stress protein in poly(adenosine diphosphate-ribose) polymerase- and nicotinamide adenine dinucleotide-deficient V79 cell lines and its relation to resistance to the topoisomerase II inhibitor etoposide. Chatterjee S; Cheng MF; Berger SJ; Berger NA Cancer Res; 1994 Aug; 54(16):4405-11. PubMed ID: 8044789 [TBL] [Abstract][Full Text] [Related]
5. Topoisomerase II inhibition and altered kinetics of formation and repair of nitrosourea and cisplatin-induced DNA interstrand cross-links and cytotoxicity in human glioblastoma cells. Ali-Osman F; Berger MS; Rajagopal S; Spence A; Livingston RB Cancer Res; 1993 Dec; 53(23):5663-8. PubMed ID: 8242621 [TBL] [Abstract][Full Text] [Related]
6. Association between the unfolded protein response, induced by 2-deoxyglucose, and hypersensitivity to cisplatin: a mechanistic study employing molecular genomics. Gaddameedhi S; Chatterjee S J Cancer Res Ther; 2009 Sep; 5 Suppl 1():S61-6. PubMed ID: 20009298 [TBL] [Abstract][Full Text] [Related]
7. Effect of inhibitors of poly(ADP-ribose) polymerase on the induction of GRP78 and subsequent development of resistance to etoposide. Chatterjee S; Cheng MF; Berger RB; Berger SJ; Berger NA Cancer Res; 1995 Feb; 55(4):868-73. PubMed ID: 7850801 [TBL] [Abstract][Full Text] [Related]
8. Schedule-dependent cytotoxicity of topotecan alone and in combination chemotherapy regimens. Cheng MF; Chatterjee S; Berger NA Oncol Res; 1994; 6(6):269-79. PubMed ID: 7865902 [TBL] [Abstract][Full Text] [Related]
9. Interference with topoisomerase IIalpha potentiates melphalan cytotoxicity. Hirota H; Gosky D; Berger NA; Chatterjee S Int J Oncol; 2002 Feb; 20(2):311-8. PubMed ID: 11788894 [TBL] [Abstract][Full Text] [Related]
10. Comparison of DNA interstrand cross-linking and strand breakage by 1,3-bis(2-chloroethyl)-1-nitrosourea in polyamine-depleted and control human adenocarcinoma cells. Seidenfeld J; Barnes D; Block AL; Erickson LC Cancer Res; 1987 Sep; 47(17):4538-43. PubMed ID: 3113720 [TBL] [Abstract][Full Text] [Related]
11. Overexpressed WAF1/Cip1 renders glioblastoma cells resistant to chemotherapy agents 1,3-bis(2-chloroethyl)-1-nitrosourea and cisplatin. Ruan S; Okcu MF; Ren JP; Chiao P; Andreeff M; Levin V; Zhang W Cancer Res; 1998 Apr; 58(7):1538-43. PubMed ID: 9537261 [TBL] [Abstract][Full Text] [Related]
12. Down-regulation of topoisomerase II alpha is caused by up-regulation of GRP78. Gosky D; Chatterjee S Biochem Biophys Res Commun; 2003 Jan; 300(2):327-32. PubMed ID: 12504087 [TBL] [Abstract][Full Text] [Related]
13. Elevated DNA polymerase alpha, DNA polymerase beta, and DNA topoisomerase II in a melphalan-resistant rhabdomyosarcoma xenograft that is cross-resistant to nitrosoureas and topotecan. Friedman HS; Dolan ME; Kaufmann SH; Colvin OM; Griffith OW; Moschel RC; Schold SC; Bigner DD; Ali-Osman F Cancer Res; 1994 Jul; 54(13):3487-93. PubMed ID: 8012971 [TBL] [Abstract][Full Text] [Related]
14. Mechanisms involved in the potentiation of melphalan by the bioreductive compound THNLA-1 in vitro. Papadopoulou MV; Ji M; Khan SH; Bloomer WD Oncol Res; 1999; 11(8):345-57. PubMed ID: 10803738 [TBL] [Abstract][Full Text] [Related]
15. DNA interstrand crosslinking and strand break repair in human glioma cell lines of varying [1,3-bis(2-chloroethyl)-1-nitrosourea] resistance. Ali-Osman F; Srivenugopal K; Berger MS; Stein DE Anticancer Res; 1990; 10(3):677-82. PubMed ID: 2164350 [TBL] [Abstract][Full Text] [Related]
16. Decreased cell survival and DNA repair capacity after UVC irradiation in association with down-regulation of GRP78/BiP in human RSa cells. Zhai L; Kita K; Wano C; Wu Y; Sugaya S; Suzuki N Exp Cell Res; 2005 May; 305(2):244-52. PubMed ID: 15817150 [TBL] [Abstract][Full Text] [Related]
17. Alkylator resistance in human B lymphoid cell lines: (2). Increased levels of topoisomerase II expression and function in a melphalan-resistant B-CLL cell line. Pu QQ; Bezwoda WR Anticancer Res; 2000; 20(4):2569-78. PubMed ID: 10953328 [TBL] [Abstract][Full Text] [Related]
18. Etoposide-resistant HT-29 human colon carcinoma cells during glucose deprivation are sensitive to piericidin A, a GRP78 down-regulator. Hwang JH; Kim JY; Cha MR; Ryoo IJ; Choo SJ; Cho SM; Tsukumo Y; Tomida A; Shin-Ya K; Hwang YI; Yoo ID; Park HR J Cell Physiol; 2008 Apr; 215(1):243-50. PubMed ID: 17941090 [TBL] [Abstract][Full Text] [Related]
19. Xrcc3 induces cisplatin resistance by stimulation of Rad51-related recombinational repair, S-phase checkpoint activation, and reduced apoptosis. Xu ZY; Loignon M; Han FY; Panasci L; Aloyz R J Pharmacol Exp Ther; 2005 Aug; 314(2):495-505. PubMed ID: 15843498 [TBL] [Abstract][Full Text] [Related]
20. Alkylator resistance in human B lymphoid cell lines: (1). Melphalan accumulation, cytotoxicity, interstrand-DNA-crosslinks, cell cycle analysis, and glutathione content in the melphalan-sensitive B-lymphocytic cell line (WIL2) and in the melphalan-resistant B-CLL cell line (WSU-CLL). Pu Q; Bianchi P; Bezwoda WR Anticancer Res; 2000; 20(4):2561-8. PubMed ID: 10953327 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]